Naproxen

Product NDC
68071-5039
11-digit product format
680715039
Labeler code
68071
Product ID
68071-5039_2d53b71b-770a-e12d-e063-6294a90a5478
Type
HUMAN OTC DRUG
Nonproprietary name
Naproxen Sodium
Dosage form
TABLET
Route
ORAL
Labeler
NuCare Pharmaceuticals,Inc.
Application
ANDA204872
Marketing category
ANDA
Marketing start
2019-01-01
Substance
NAPROXEN SODIUM
Active strength
220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage68071-5039-1302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage68071-5039-1ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage68071-5039-10efc9e666f02…f202fb6c5f17…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A204872-001NAPROXEN SODIUMNAPROXEN SODIUM220MGTABLET / ORAL2017-01-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-2331067a03dcf5…
2025-08-23 18:47 UTC2025-08A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-236a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-2303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-232680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-235bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-2379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-231e350fbaab3a…
2024-05-31 18:47 UTC2024-05A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-238072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-235c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-235d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-234b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-2374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-2387673890dc5c…
2021-03-12 10:30 UTC2021-03A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-235aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-238869cabd3fbd…
2020-11-12 02:37 UTC2020-11A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23c0c555d07b60…
2019-12-14 00:12 UTC2019-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-233f01610625f2…
2019-09-15 20:21 UTC2019-09A204872-001NAPROXEN SODIUMEQ 200MG BASETABLET / ORAL2017-01-23b00525d2431f…
2019-07-19 19:46 UTC2019-07A204872-001NAPROXEN SODIUMEQ 200MG BASETABLET / ORAL2017-01-23ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-236a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-231c564ffb4f44…
2023-12-20 04:57 UTC2023-12A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-239b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-233f0d92c62455…
2023-05-13 08:27 UTC2023-05A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23053a50430f4f…
2023-01-26 05:58 UTC2023-01A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-233bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-233a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A204872-001NAPROXEN SODIUM220MGTABLET / ORAL2017-01-23cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Naproxen
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NAPROXEN SODIUM220 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9TN87S3A3CInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
849574Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
f1ed8384-83d6-6f2a-e053-2a95a90ab08fAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68071-5039-12025-02-04C16284748780-12cef2736-a0fb-d83d-e063-dadaa90ab31fgc 951-954L
68071-5039-12025-01-30C16284748780-12cef2736-a0fb-d83d-e063-dadaa90ab31fgc 951-954L

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-5039-1Naproxen21 in 1 BOTTLETABLET213

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-5039NAPROXEN (NAPROXEN SODIUM) TABLET [NUCARE PHARMACEUTICALS,INC.]3Current NDC, Legacy NDC, 1 package rows20250206_f1ed8384-83d6-6f2a-e053-2a95a90ab08f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 28 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NaproxenNAPROXEN SODIUMPreferred Pharmaceuticals, Inc.20eb9d9f-11df-464f-a1b0-949f8fda40422026-07-28WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Back and Muscle PainNAPROXEN SODIUMCVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED4039504c-e612-4503-854a-62ee067809562026-07-13WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen SodiumNAPROXEN SODIUMLidl US LLC3d01220c-c5ec-4604-8cef-9ecb807ccd532026-06-22WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen SodiumNAPROXEN SODIUMRite Aid Corporation134e5ec6-c42a-43b6-adf2-2d7546875ead2026-06-19WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen Headache PainNAPROXEN SODIUML.N.K. International, Inc.6161b881-f422-47ae-86ba-a28d669bce792026-06-18WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
NaproxenNAPROXEN SODIUMFamily Dollar Services Incd9c63e1f-c2ad-434b-8a21-7fff21b7477b2026-06-03WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen SodiumNAPROXEN SODIUMRite Aid Corporatione6277515-c606-4535-9c29-08cade045aee2026-05-14WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen Back and Muscle PainNAPROXEN SODIUML.N.K. International, Inc.68944663-0dc0-4d3a-a36b-019061bdbfa02026-03-09WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
AnaDentNAPROXEN SODIUMBelmora LLC236674db-da4d-415c-a160-7086eaf5bff52026-03-03WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen SodiumNAPROXEN SODIUML.N.K. International, Inc.717518e4-2537-4229-b765-c6acfe963d4b2026-02-25WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen SodiumNAPROXEN SODIUMBetter Living Brands, LLC3eeb07fe-fcf1-4ea7-b0c2-9cb04f88c0412026-02-13WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Back and Muscle PainNAPROXEN SODIUMRite Aid Corporatione162bd50-f94a-4c76-8f1b-62114f2838092026-02-11WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Flanax Menstrual Pain RelieverNAPROXEN SODIUMBelmora LLC2b4135b3-389c-46e2-ae86-7674c2ab9a322026-01-27WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
FlanaxNAPROXEN SODIUMBelmora LLC2c099d45-f03a-4161-a6af-8fe5965f27482026-01-06WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
All Day Pain ReliefNAPROXEN SODIUMWALMART INC.c4909e43-57ba-44bc-a234-a02cc884891c2025-12-11WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
24/7 Life by 7-Eleven Naproxen SodiumNAPROXEN SODIUM TABLET, FILM COATEDLil' Drug Store Products, Inc.44716954-006a-4c56-e063-6294a90a0f142025-11-25WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
Naproxen SodiumNAPROXEN SODIUMAthlete's Needs Incd5984c9d-3941-45d6-8392-87564b2faae02025-11-15WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
NaproxenNAPROXEN SODIUMBetter Living Brands, LLC43745d42-f859-4168-a2dd-2c8ae47ae5902025-10-28WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
NaproxenNAPROXEN SODIUMFamily Dollar Services Incb6205032-f5c6-494a-8b87-adbbbc3982e72025-10-27WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872
NaproxenNAPROXEN SODIUMAmerisource Bergen1e2e6e3a-b095-4d5b-86fe-61eb44a87cf02025-10-20WarningsExact identifier
application applno (ANDA): 204872
application number: ANDA204872

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
849574naproxen sodium 220 MG Oral TabletPSNf1ed8384-83d6-6f2a-e053-2a95a90ab08f3
849574naproxen sodium 220 MG Oral TabletSCDf1ed8384-83d6-6f2a-e053-2a95a90ab08f3
849574naproxen sodium 220 MG (as naproxen 200 MG) Oral TabletSYf1ed8384-83d6-6f2a-e053-2a95a90ab08f3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68071-5039-16807150390121 TABLET in 1 BOTTLE (68071-5039-1) 21 tablet2023-01-100000-00-00NoNoCurrent